329 related articles for article (PubMed ID: 25380841)
41. Longitudinal and cross-sectional effects of C-reactive protein, equilibrated normalized protein catabolic rate, and serum bicarbonate on creatinine and albumin levels in dialysis patients.
Kaysen GA; Greene T; Daugirdas JT; Kimmel PL; Schulman GW; Toto RD; Levin NW; Yan G;
Am J Kidney Dis; 2003 Dec; 42(6):1200-11. PubMed ID: 14655192
[TBL] [Abstract][Full Text] [Related]
42. Orally administrated Juzen-taiho-to/TJ-48 ameliorates erythropoietin (rHuEPO)-resistant anemia in patients on hemodialysis.
Nakamoto H; Mimura T; Honda N
Hemodial Int; 2008 Oct; 12 Suppl 2():S9-S14. PubMed ID: 18837771
[TBL] [Abstract][Full Text] [Related]
43. Association of depression with markers of nutrition and inflammation in chronic kidney disease and end-stage renal disease.
Kalender B; Ozdemir AC; Koroglu G
Nephron Clin Pract; 2006; 102(3-4):c115-21. PubMed ID: 16282695
[TBL] [Abstract][Full Text] [Related]
44. Association of left ventricular hypertrophy with high-sensitive C-reactive protein in hemodialysis patients.
Monfared A; Salari A; Kazemnezhad E; Lebadi M; Khosravi M; Mehrjardi NK; Rahimifar S; Amini N
Int Urol Nephrol; 2013 Dec; 45(6):1679-86. PubMed ID: 23306861
[TBL] [Abstract][Full Text] [Related]
45. IL-18 is involved in vascular injury in end-stage renal disease patients.
Porazko T; Kúzniar J; Kusztal M; Kúzniar TJ; Weyde W; Kuriata-Kordek M; Klinger M
Nephrol Dial Transplant; 2009 Feb; 24(2):589-96. PubMed ID: 18775894
[TBL] [Abstract][Full Text] [Related]
46. Serum-soluble Fas and serum levels of erythropoietin in chronic kidney disease.
Góes MA; Dalboni MA; Manfredi SR; Cendoroglo MS; Batista MC; Canziani ME; Balakrishnan VS; Pereira BJ; Draibe SA; Cendoroglo M
Clin Nephrol; 2010 Jan; 73(1):7-13. PubMed ID: 20040346
[TBL] [Abstract][Full Text] [Related]
47. Persistent elevation of C-reactive protein may predict cardiac hypertrophy and dysfunction in patients maintained on hemodialysis.
Kim BS; Jeon DS; Shin MJ; Kim YO; Song HC; Lee SH; Kim SY; Choi EJ; Chang YS; Bang BK
Am J Nephrol; 2005; 25(3):189-95. PubMed ID: 15863980
[TBL] [Abstract][Full Text] [Related]
48. Hepcidin/Ferritin Ratios Differ Among Non-Dialyzed Chronic Kidney Disease Patients, and Patients on Hemodialysis and Peritoneal Dialysis.
Niikura T; Maruyama Y; Nakashima S; Matsuo N; Tanno Y; Ohkido I; Yokoyama K; Yamamoto H; Yokoo T
Ther Apher Dial; 2019 Aug; 23(4):341-346. PubMed ID: 30411489
[TBL] [Abstract][Full Text] [Related]
49. Predictors of serum creatinine in haemodialysis patients: a cross-sectional analysis.
Vernaglione L; Marangi AL; Cristofano C; Giordano R; Chimienti S; Basile C
Nephrol Dial Transplant; 2003 Jun; 18(6):1209-13. PubMed ID: 12748357
[TBL] [Abstract][Full Text] [Related]
50. Reticulocyte hemoglobin content in hemodialysis patients with acute infection.
Mitsuiki K; Harada A; Miyata Y
Clin Exp Nephrol; 2004 Sep; 8(3):257-62. PubMed ID: 15480904
[TBL] [Abstract][Full Text] [Related]
51. Hepatocyte growth factor predicts survival and relates to inflammation and intima media thickness in end-stage renal disease.
Malatino LS; Mallamaci F; Benedetto FA; Bellanuova I; Cataliotti A; Tripepi G; Zoccali C
Am J Kidney Dis; 2000 Nov; 36(5):945-52. PubMed ID: 11054350
[TBL] [Abstract][Full Text] [Related]
52. A Comparative Study of C-Reactive Protein Plasma Levels in Patients on Hemodialysis and Peritoneal Dialysis.
Fernández-Reyes MJ; Hevia C; Bajo MA; Peso GD; Costero O; Diez JJ; Selgas R
Hemodial Int; 2001 Jan; 5(1):55-58. PubMed ID: 28452446
[TBL] [Abstract][Full Text] [Related]
53. Soluble transferrin receptors and reticulocyte hemoglobin concentration in the assessment of iron deficiency in hemodialysis patients.
Fusaro M; Munaretto G; Spinello M; Rebeschini M; Amici G; Gallieni M; Piccoli A
J Nephrol; 2005; 18(1):72-9. PubMed ID: 15772926
[TBL] [Abstract][Full Text] [Related]
54. Regression Correction Equation to Adjust Serum Iron and Ferritin Concentrations Based on C-Reactive Protein and Albumin in Patients Receiving Primary and Secondary Care.
McSorley ST; Tham A; Jones I; Talwar D; McMillan DC
J Nutr; 2019 May; 149(5):877-883. PubMed ID: 31050746
[TBL] [Abstract][Full Text] [Related]
55. Correlation of serum lead levels with inflammation, nutritional status, and clinical complications in hemodialysis patients.
Pouresmaeil R; Razeghi E; Ahmadi F
Ren Fail; 2012; 34(9):1114-7. PubMed ID: 22889119
[TBL] [Abstract][Full Text] [Related]
56. [Iron deficiency reduces systemic inflammation in obese women].
Nedoborenko VM; Lavrenko AV; Mamontova TV; Vesnina LE; Kaidashev IP
Wiad Lek; 2018; 71(2 pt 2):326-330. PubMed ID: 29786580
[TBL] [Abstract][Full Text] [Related]
57. Inflammatory markers and platelet aggregation tests as predictors of hemoglobin and endogenous erythropoietin levels in hemodialysis patients.
Borawski J; Pawlak K; Myśliwiec M
Nephron; 2002 Aug; 91(4):671-81. PubMed ID: 12138272
[TBL] [Abstract][Full Text] [Related]
58. Brain natriuretic peptide between traditional and nontraditional risk factors in hemodialysis patients: analysis of cardiovascular mortality in a two-year follow-up.
Selim G; Stojceva-Taneva O; Spasovski G; Georgievska-Ismail L; Zafirovska-Ivanovska B; Gelev S; Dzekova P; Trajcevska L; Trojacanec-Piponska S; Sikole A
Nephron Clin Pract; 2011; 119(2):c162-70. PubMed ID: 21757955
[TBL] [Abstract][Full Text] [Related]
59. Comparison of reticulocyte hemoglobin equivalent with traditional markers of iron and erythropoiesis in pediatric dialysis.
Davidkova S; Prestidge TD; Reed PW; Kara T; Wong W; Prestidge C
Pediatr Nephrol; 2016 May; 31(5):819-26. PubMed ID: 26667237
[TBL] [Abstract][Full Text] [Related]
60. Significance of albumin and C-reactive protein variations in 300 end stage renal disease patients in Tehran University of Medical Sciences Hospitals during year 2010.
Dashti N; Einollahi N; Nabatchian F; Moradi Sarabi M; Zarebavani M
Acta Med Iran; 2012; 50(3):197-202. PubMed ID: 22418989
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
